BRAND: Omeprazole Rowa
ACTIVE INGREDIENT: Omeprazole
STRENGTH, PACK SIZE & GMS CODES:
20 mg Gastro-Resistant Capsules, hard ~ 61853
40 mg Gastro-Resistant Capsules, hard ~ 36509
Omeprazole Rowa is indicated in:
Treatment of: duodenal ulcers, gastric ulcers, NSAID-associated gastric and duodenal ulcers, reflux esophagitis, symptomatic gastro-esophageal reflux disease, Zollinger-Ellison syndrome.
Prevention of: relapse of duodenal ulcers, relapse of gastric ulcers, NSAID-associated gastric and duodenal ulcers in patients at risk.
In combination with: appropriate antibiotics, Helicobacter pylori (H. pylori) eradication in peptic ulcer disease.
Long-term: management of patients with healed reflux esophagitis.
Children over 1 year of age and ≥ 10 kg
- Treatment of reflux esophagitis
- Symptomatic treatment of heartburn and acid regurgitation in gastro-esophageal reflux disease
Children and adolescents over 4 years of age
- In combination with antibiotics in treatment of duodenal ulcer caused by H. pylori
Download Omeprazole Rowa 20mg SPC and Patient Information Leaflet here
Download Omeprazole Rowa 40mg SPC and Patient Information Leaflet here